[1] KOLIAKI C, LIATIS S, DALAMAGA M, et al. Sarcopenic obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives[J]. Curr Obes Rep, 2019, 8(4):458-471. [2] BATSIS J A, VILLAREAL D T. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies[J]. Nat Rev Endocrinol, 2018, 14(19):513-537. [3] ATMIS V, YALCIN A, SILAY K, et al. The relationship between all-cause mortality sarcopenia and sarcopenic obesity among hospitalized older people[J]. Aging Clin Exp Res, 2019, 31(11):1563-1572. [4] LEE D, SHOOK R P, DRENOWATZ C, et al. Physical activity and sarcopenic obesity: definition, assessment, prevalence and mechanism[J]. Future Sci OA, 2016, 2(3):2016-2028. [5] BATSIS J A, BARRE L K, MACKENZIE T A, et al. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: Dual-Energy X-Ray Absorptiometry Data from the National Health and Nutrition Examination Survey 1999-2004[J]. J Am Geriatr Soc, 2013, 61(6):974-980. [6] BATSIS J A, MACKENZIE T A, EMENY R T, et al. Low lean mass with and without obesity, and mortality: results from the 1999-2004 national health and nutrition examination survey[J]. J Gerontol A Biol Sci Med Sci, 2017, 72(10):1445-1451. [7] KIM Y S, LEE Y, CHUNG Y S, et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys[J]. J Gerontol A Biol Sci Med Sci, 2012, 67(10):1107-1113. [8] 程小秋, 邓笑伟, 刘佚, 等. 不同诊断标准对老年少肌性肥胖的检出率[J]. 中华灾害救援医学, 2017, 5(1):45-48. [9] WANG H, HAI S, LIU Y X, et al. Associations between sarcopenic obesity and cognitive impairment in elderly Chinese community-dwelling individuals[J]. J Nutr Health Aging, 2019, 23(1):14-20. [10] STENHOLM S, ALLEY D, BANDINELLI S, et al. The effect of obesity combined with low muscle strength on decline in mobility in older persons: results from the InCHIANTI Study[J]. Int J Obes: Lond,2009, 33(6):635-644. [11] BAUMGARTNERA R N. Body composition in healthy aging[J]. Ann N Y Acad Sci, 2000, 904:437-448. [12] SHAO A, CAMPBELL W W, CHEN C O, et al. The emerging global phenomenon of sarcopenic obesity: role of functional foods; a conference report[J]. J Funct Foods, 2017, 33:244-250. [13] KENDLER D L, BORGES J L C, FIELDING R A, et al. The official positions of the international society for clinical densitometry: Indications of Use and Reporting of DXA for Body Composition[J]. J Clin Densitom, 2013, 16(4):496-507. [14] VELLAS B, FIELDING R A, BENS C, et al. Implications of ICD-10 for sarcopenia clinical practice and clinical trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force[J]. J Frailty Aging, 2018, 7(1):2-9. [15] CRUZ-JENTOFT A J, BAEYENS J P, BAUER J M, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People[J]. Age Ageing, 2010, 39(4):412-423. [16] STUDENSKI S A, PETERS K W, ALLEY D E, et al. The FNIH sarcopenia project: Rationale, Study Description, Conference Recommendations, and Final Estimates[J]. J Gerontol A Biol Sci Med Sci, 2014, 69(5):547-558. [17] CRUZ-JENTOFT A J, BAHAT G, BAUER J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(4):601. [18] NEWMAN A B, KUPELIAN V, VISSER M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort[J]. J Gerontol A Biol Sci Med Sci, 2006, 61(1):72-77. [19] FIELDING R A, VELLAS B, EVANS W J, et al. Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia[J]. J Am Med Dir Assoc, 2011, 12(4):249-256. [20] CHEN L, WOO J, ASSANTACHAI P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment[J]. J Am Med Dir Assoc, 2020, 21(3):300-307. [21] SCHRAGER M A, METTER E J, SIMONSICK E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study[J]. J Appl Physiol, 2007, 102(3):919-925. [22] GARVEY W T, MECHANICK J I, BRETT E M, et al. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity[J]. Endocr Pract, 2016, 22(7):842-884. [23] PERNA S, SPADACCINI D, RONDANELLI M. Sarcopenic obesity: time to target the phenotypes[J]. J Cachexia Sarcopenia Muscle, 2019, 10(3):710-711. |